Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders

Millions of people die from liver diseases annually, and liver failure is one of the three major outcomes of liver disease. The gut microbiota plays a crucial role in liver diseases. This study aimed to explore the effects of Lactobacillus casei strain Shirota (LcS), a probiotics used widely around...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Ren, Wang, Kaicen, Wang, Qiangqiang, Jiang, Huiyong, Lu, Yingfeng, Chen, Xiaoxiao, Zhang, Hua, Su, Xiaoling, Du, Yiling, Chen, Lifeng, Li, Lanjuan, Lv, Longxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719798/
https://www.ncbi.nlm.nih.gov/pubmed/33492728
http://dx.doi.org/10.1111/1751-7915.13750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719798/
https://www.ncbi.nlm.nih.gov/pubmed/33492728
http://dx.doi.org/10.1111/1751-7915.13750

Ejemplares similares